Topically applied medications are a cornerstone of the field-directed treatment of actinic keratoses. In photodynamic therapy, a topical agent is combined with a procedural method. In cases of insufficient response, severe hyperkeratosis or in high-risk patients, other combined therapy strategies can also be considered, such as lesion-directed destruction of individual lesions followed by field-directed therapy. Immunocompromised patients have an increased risk of progression from AK lesions to cutaneous squamous cell carcinoma.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Sleep disorder
Sleep medicine in transition: new goals and a reassessment of old hypnotics
- Ginkgo biloba extract in the Alzheimer's mouse model
Effects on disease-associated microglia subpopulations
- "Patients W.A.I.T Indicator"
Access to medicines – how does Switzerland compare across Europe?
- Adherence in severe or poorly controlled asthma
Digital monitoring with potential for greater treatment adherence
- Crohn's disease and depression
Significant psychological stress for CD patients
- Epilepsy
Cannabidiol for refractory epilepsy syndromes
- Stomach cancer and Helicobacter pylori
A question of income?
- Prurigo nodularis and AD